Global CGM Market will be US$ 5.6 Billion by 2025 | Study with COVID-19 Impact

According to the latest report by Renub Research, titled “Continuous Glucose Monitoring (CGM) Market, Users, Reimbursement Policy, Global Analysis, CGM Components Market, Diabetes (Type1 & 2) Population, & Forecast” Medical science is undergoing massive development from the past few years. There has been tremendous research and development in blood glucose monitoring devices due to this Continuous Glucose Monitoring (CGM) is the result of this invention. CGM is one of the recent developments in the field of diabetes management. It monitors blood glucose through subcutaneous by inserting a biosensor or by transcutaneous. This embedded sensor monitors the glucose level in blood or interstitial fluid and then transmits data to the receiver/monitor using a transmitter, which become helpful in the treatment of diabetics. According to Renub Research report, the Global CGM Market is anticipated to be US$ 5.6 Billion by the end of the year 2025.

Due to all these several benefits of Continuous Glucose Monitor over other monitoring devices, this has become a vital device for management of diabetes, especially for Type1 diabetes patients. It gives details for blood glucose continuously as compared to the traditional glucose monitor, which offers one time result. Multiple medical device companies are investing heavily in the development of producing technologically advanced Contiguous Blood Glucose Monitor System to have a competitive advantage over other healthcare companies.

COVID-19 impact on Continuous Glucose Monitoring Systems

COVID-19 has affected global healthcare system, and diabetes management is one of them. Currently, healthcare facilities are focusing on the treatment of COVID-19 patients, and other patients are not receiving medical facilities as they were receiving in the past. Most of the health experts are providing consultation through telehealth systems.

Factors Driving the Continuous Glucose Monitoring Industry

The market for blood glucose is growing due to increasing number of diabetic patients worldwide as people are following a sedentary lifestyle. Another reason increasing per capita income, rise in computer uses that leads to obesity, lack of physical activity, consumption of unhealthy meals, an increasing number of geriatric population. Healthcare facilities are also receiving massive funding from various resources; this will also help diabetic patients in the long run. Systems like CGM will become more technically advanced in upcoming years.

About Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises of major players in Life Sciences, Information Technology, Telecom, Financial Services (Banking, Insurance), Energy, Retail, Manufacturing, Automotive, and Social sector. Our clients rely on our market analysis and data to make informed knowledgeable decisions. We are regarded as one of the best providers of knowledge. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91-120-421-9822 (IND)
Follow on Linkedin: